$IMDX
Insight Molecular Diagnostics Inc. Common Stock
XNAS•Health Care•In Vitro & in Vivo Diagnostic Substances
$4.00
▲+11.73%+$0.420
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateInsight Molecular Diagnostics Inc. Common Stock
XNAS•Health Care•In Vitro & in Vivo Diagnostic Substances
Why is IMDX up today? It is at $4.00 (+11.73%), and our scanner flagged it 14 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment IMDX spikes, and full due diligence on IMDX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $IMDX 14 times in the last 30 days. Create a free account to track $IMDX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on IMDX from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Arno Andrew Director | Sold (automatic/other) | -12K 0.04% of company | sold 7.2% | 157K | $69K at $5.69 | Jul 1, 26 |
Last Andrew J. Director | Sold (automatic/other) | -8K 0.02% of company | sold 12% | 59K | $44K at $5.69 | Jul 1, 26 |
Silverman Lou Director | Sold (automatic/other) | -8K 0.02% of company | sold 12% | 56K | $44K at $5.69 | Jul 1, 26 |
Last Andrew J. Director | Acquired (grant/award) | +27K 0.08% of company | added 68% | 66K | n/a | Jun 11, 26 |
Arno Andrew Director | Acquired (grant/award) | +32K 0.10% of company | added 24% | 169K | n/a | Jun 11, 26 |
Silverman Lou Director | Acquired (grant/award) | +27K 0.08% of company | added 74% | 64K | n/a | Jun 11, 26 |
Broadwood Partners, L.P. Beneficial Owner (10%) | Bought (open market) | +251K 0.8% of company | added 2.0% | 12.68M | $913K at $3.64 | Apr 27, 26 |
Broadwood Partners, L.P. Beneficial Owner (10%) | Bought (open market) | +39K 0.1% of company | added 0.3% | 12.43M | $137K at $3.53 | Apr 24, 26 |
Broadwood Partners, L.P. Beneficial Owner (10%) | Bought (open market) | +280K 0.9% of company | added 2.3% | 12.40M | $981K at $3.50 | Apr 23, 26 |
Broadwood Partners, L.P. Beneficial Owner (10%) | Bought (open market) | +41K 0.1% of company | added 0.3% | 12.11M | $158K at $3.88 | Apr 20, 26 |
Broadwood Partners, L.P. Beneficial Owner (10%) | Bought (open market) | +40K 0.1% of company | added 0.3% | 12.07M | $143K at $3.57 | Apr 17, 26 |
Broadwood Partners, L.P. Beneficial Owner (10%) | Bought (open market) | +102K 0.3% of company | added 0.9% | 12.03M | $352K at $3.45 | Apr 16, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in in vitro & in vivo diagnostic substances, closest in size first.
Here is the latest on IMDX from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
IMDX last traded at $4.00, up 11.73% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Insight Molecular Diagnostics Inc. Common Stock (IMDX) is next expected to report earnings on Monday, November 9, 2026, about 53 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The IMDX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged IMDX 14 times in the last 30 days.
IMDX (Insight Molecular Diagnostics Inc. Common Stock) trades on XNAS, with a market cap of about $117M in the In Vitro & In Vivo Diagnostic Substances sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge IMDX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$IMDX discussion
Sign in to ask a question or join the discussion.